We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Immunicon (MM) | NASDAQ:IMMC | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.19 | 0 | 01:00:00 |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): March 14, 2008
IMMUNICON CORPORATION
(Exact Name of Registrant Specified in Charter)
Delaware | 000-50677 | 23-2269490 | ||
(State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
3401 Masons Mill Road, Suite 100 Huntingdon Valley, Pennsylvania |
19006 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrants telephone number, including area code: (215) 830-0777
Not Applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions ( see General Instruction A.2. below):
¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. |
The Board of Directors (the Board) of Immunicon Corporation, a Delaware corporation (Immunicon), appointed Teresa O. Lipcsey as its new principal accounting officer, effective as of March 14, 2008. Ms. Lipcsey assumed the role of principal accounting officer from James G. Murphy, whose resignation as Immunicons Senior Vice President, Finance and Administration and Chief Financial Officer was effective as of March 14, 2008.
Ms. Lipcsey, 42, has served as Vice President and Corporate Controller of Immunicon since January 2005. From December 2003 to January 2005, Ms. Lipcsey served as Executive Director and Controller of Immunicon. From May 1999 to December 2003, Ms. Lipcsey was Corporate Controller of Integrated Circuit Systems, Inc., a formerly public semiconductor company that designed, developed and marketed silicon timing devices. Ms. Lipcsey holds a B.S. in Accounting and Finance from University of Maryland and is a certified public accountant and a certified treasury professional.
Ms. Lipcseys current annual salary is $200,000 and she is eligible to participate in the benefit plans generally offered to Immunicon officers and employees. In addition, Immunicon has agreed to provide Ms. Lipcsey with a severance package if she is terminated by Immunicon (and her performance prior to that termination is satisfactory) consisting of a lump sum payment equal to nine (9) months of her base salary and continuation of certain benefits under Immunicons benefit plans for the one (1) month period following her termination. If Ms. Lipcsey agrees to sign a waiver at her termination under those circumstances, Immunicon has also agreed to continue certain benefits under Immunicons benefit plans for a further two (2) month period in addition to the one (1) month period described above.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, Immunicon has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
IMMUNICON CORPORATION |
||
By: |
/s/ BYRON D. HEWETT |
|
Byron D. Hewett | ||
President and Chief Executive Officer |
Dated: March 20, 2008
1 Year Immunicon Chart |
1 Month Immunicon Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions